Quarterly Activities/Appendix 4C Cash Flow Report
| Stock | ECS Botanics Holdings Ltd (ECS.ASX) |
|---|---|
| Release Time | 20 Jul 2026, 8:29 a.m. |
| Price Sensitive | Yes |
ECS Botanics Reports Positive Q4 FY26 Cash Flow
- Fourth consecutive quarter of positive operating cash flow
- FY26 operating cash flow improves by $5.9 million
- Branded B2C revenue increases by 31% year-on-year
- Expansion into European markets with successful German launch
- Launch of new Australian-grown Terphogz product
ECS Botanics Holdings Ltd (ASX:ECS) reported a fourth consecutive quarter of positive operating cash flow, delivering $310k in Q4 FY26 from customer receipts of $5.1 million. The company's FY26 operating cash flow improved by $5.9 million from the $5.1 million outflow in FY25. Customer receipts increased by 12% quarter-on-quarter to $5.1 million. Branded B2C revenue grew 31% year-on-year to $3.45 million, representing 71% of quarterly revenue. FY26 revenue reached approximately $21.0 million, up 8% year-on-year. Cultivation performance improved with a 12% increase in outdoor trimmed flower yield and a 43% rise in PCE production. European expansion advanced with OzSun's initial German shipment selling out quickly and the first Polish product application progressing. ECS launched Gelonoidz #20, the first Australian-grown Terphogz product, expanding its premium branded portfolio. The company ended the quarter with cash of $1.7 million and undrawn corporate loan facilities of $2.8 million, providing total available funding of approximately $4.5 million.
FY26 operating cash flow of $788k
ECS aims to continue growing branded B2C sales, scale OzSun in Germany, increase export revenue, expand product portfolios, and improve yields and production efficiency in FY27.